↓ Skip to main content

Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery

Overview of attention for article published in Molecular Pharmaceutics, June 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery
Published in
Molecular Pharmaceutics, June 2022
DOI 10.1021/acs.molpharmaceut.2c00292
Pubmed ID
Authors

Daniel Porat, Oleg Dukhno, Ella Vainer, Sandra Cvijić, Arik Dahan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 43%
Student > Bachelor 1 14%
Student > Postgraduate 1 14%
Student > Master 1 14%
Unknown 1 14%
Readers by discipline Count As %
Unspecified 3 43%
Pharmacology, Toxicology and Pharmaceutical Science 1 14%
Medicine and Dentistry 1 14%
Unknown 2 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2023.
All research outputs
#15,282,784
of 24,240,330 outputs
Outputs from Molecular Pharmaceutics
#2,106
of 4,385 outputs
Outputs of similar age
#214,284
of 429,356 outputs
Outputs of similar age from Molecular Pharmaceutics
#41
of 110 outputs
Altmetric has tracked 24,240,330 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,385 research outputs from this source. They receive a mean Attention Score of 4.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,356 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.